Fonds de solidarité FTQ invests $8.8 mln in Milestone's IPO
Fonds de solidarité FTQ invested $8.8 million in the initial public offering (IPO) of Milestone Pharmaceuticals Inc, a Montréal-based developer of therapies for treating episodic cardiovascular conditions. Milestone completed its IPO on the Nasdaq Stock Market this month, raising about $111 million (US$82.5 million). Fonds de solidarité FTQ, a Canadian provider of development capital, has backed Milestone, directly and as a fund investor, since the company's founding in 2005 by CSO Philippe Douville. Its total investment prior to the IPO was $17.3 million.
15 May 2019•3 mins read
